<p><strong>Gapping Down</strong><br /><u>Select financial related names trading lower following extended domestic holiday weekend and weakness in overseas trading exacerbated by ECB report raising concerns on further write-downs</u>: IRE -8.4%, AIB -6.8%, BBVA -5.1%, CS -3.8%, RDN -3.7%, STD -3.3%, NBG -3.3%, BCS -2.9%, AIG -2.9% (AIG to adhere to original AIA transaction terms), UBS -2.9%, RF -2.8%, GNW -2.8%, ING -2.8%, KEY -2.4%, C -1.5%, JPM -1.4%.</p><p><u>Select metals/mining stocks trading lower</u>: SLT -6.0%, MT -4.4%, RTP -2.4%, TOT -2.2%, BHP -2.4%, BBL -1.6%.</p><p><u>Select oil/gas related names showing weakness:</u> BP -15.0% (plans to further enhance lower marine riser package containment system), RIG -8.2%, ATPG -7.9%, ESV -6.4%, APC -6.4%, CAM -3.9%, WFT -3.5%, DO -3.3%, BHI -2.9%, HAL -3.3%, NBR -2.8%, SLB -2.0%, CVX -1.1%.</p><p><u>Other news:</u> ACGY -8.0% (trading ex dividend).</p><p><u>Analyst comments:</u> BEAT -7.9% (downgraded to Sell from Hold at Citigroup), RGC -6.2% (downgraded to Neutral from Buy at Janney Montgomery Scott), BYD -2.8% (downgraded to Sell from Neutral at Janney Montgomery Scott), GLW -2.5% (downgraded to Neutral from Buy at Ticonderoga), S -1.9% (initiated with a Sell at BTIG).</p><p><strong>Gapping up</strong><br /><u>In reaction to strong earnings/guidance</u>: RYAAY +5.7% (light volume).</p><p><u>M&A news:</u> EVVV +17.9% (agrees to be acquired by Covidien for $22.50 per share in cash, or $2.6 bln; COV sees FY10 dilution of $0.05-0.08, FY11 accretion of $0.10-0.15).</p><p><u>Select gold related names ticking higher</u>: GG +1.5%, EGO +1.5%, NEM +1.3%, GOLD +0.9%.</p><p><u>Other news:</u> ONCY +9.2% (receives approval from Belgium FAMHP to conduct Phase 3 Trial for REOLYSIN), OREX +8.5% (announces FDA acceptance of Contrave new drug application for the treatment of obesity), PUK +6.7% (AIG to adhere to original AIA transaction terms ), RSH +6.7% (still checking), IGTE +6.2% (still checking).</p>